October 12, 2012
A Questcor Pharmaceuticals Inc. shareholder on Thursday lodged a derivative complaint against the company's top executives, accusing them of lying about the efficacy of their main drug to inflate the price of the company's stock shortly before Aetna Inc. reduced reimbursements for it.